J. Goldman & Co’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

J. Goldman & Co’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,333	Closed	-$9.89K	–	536
2022 Q4	$9.89K	Hold	33,333	–	–	﹤0.01%	339
2022 Q3	$3K	Hold	33,333	–	–	﹤0.01%	372
2022 Q2	$8K	Hold	33,333	–	–	﹤0.01%	340
2022 Q1	$13K	Hold	33,333	–	–	﹤0.01%	347
2021 Q4	$23K	Hold	33,333	–	–	﹤0.01%	335
2021 Q3	$23K	Hold	33,333	–	–	﹤0.01%	331
2021 Q2	$35K	Buy	+33,333	New	+$326K	﹤0.01%	382

J. Goldman & Co's MSAC Position: Q3 2021 in Review

J. Goldman & Co sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q3 2021, closing a stake of 300,000 shares — an estimated $2.89M sold.

J. Goldman & Co first reported a position in MSAC in Q2 2021 and held it in 1 quarter. The position peaked at $2.9M in Q2 2021. 46 funds tracked by Wall St. Rank hold MSAC as of Q3 2021.

J. Goldman & Co reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q3 2021 after selling out during the quarter.
J. Goldman & Co sold 300,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q3 2021, an estimated $2.89M.
J. Goldman & Co first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 1 quarter.
J. Goldman & Co's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $2.9M in Q2 2021.
46 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q3 2021.

Based on J. Goldman & Co's 13F filing for Q3 2021, filed 15 Nov 2021.